Nicotine Becomes Second-Largest Revenue Source for Couche-Tard in Fiscal 2025

Market
Feb.19
Nicotine Becomes Second-Largest Revenue Source for Couche-Tard in Fiscal 2025
Alimentation Couche-Tard reported that nicotine products accounted for 9% of total revenue in fiscal 2025, making it the company’s second-largest revenue source after fuel, according to its latest Business Strategy Update.

Key Points

 

  • Nicotine accounted for 9% of Couche-Tard’s total revenue in fiscal 2025, ranking second after fuel.

 

  • The company reported a 22% share of the U.S. modern oral market and a 17% share of the cigarette market.

 

  • Traditional cigarette sales declined, while consumption of modern nicotine alternatives such as vaping and white nicotine increased.

 

  • Fuel represented 74% of revenue, with beverages contributing 8%, according to the company’s Business Strategy Update.

 


 

2Firsts, February 18, 2026 

 

According to CSP, Alimentation Couche-Tard said fuel, nicotine and beverages remained the primary performance drivers in fiscal 2025, according to its Business Strategy Update released last week.

 

Fuel accounted for 74% of total revenue in 2025. The company reported selling 15.4 billion gallons during the year, with approximately 13,000 stores—about 90% of its global network as of the end of the second quarter of fiscal 2026—offering fuel.

 

Nicotine was the second-largest revenue source, representing 9% of total revenue. In the United States, Couche-Tard reported holding a 22% share of the modern oral nicotine market and a 17% share of the cigarette market, citing Nielsen and company data.

 

“Our customer is choosing to either broaden or substitute the products that they’ve traditionally used into these more modern products,” said Louise Warner, Senior Vice President of North America and Global Commercial Optimization. She added that while traditional cigarette products have declined, consumption of modern alternatives such as vaping and white nicotine has increased.

 

Warner said the company works closely with manufacturers to monitor category trends and ensure product availability. In one campaign conducted in partnership with manufacturers, customers who purchased any nicotine product received a free can of Zyn over a four-week period. The company distributed millions of cans during the promotion, which Warner said helped maintain customer momentum.

 

Beverages accounted for 8% of revenue. The company noted that energy drinks have continued to drive growth within the beverage category.

 

Alimentation Couche-Tard, headquartered in Laval, Quebec, ranks No. 2 on CSP’s 2025 Top 202 ranking of U.S. convenience-store chains by store count.

 

(cover image source: corporate: couche-tard.com)

 


 

About Alimentation Couche-Tard

 

Alimentation Couche-Tard Inc. is a Canada-based global operator of convenience stores and fuel retail businesses, headquartered in Laval, Quebec. The company operates under several banners, including Circle K, and is ranked No. 2 on CSP’s 2025 Top 202 ranking of U.S. convenience-store chains by store count. Couche-Tard operates approximately 13,000 stores worldwide, the majority of which offer fuel services.

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

West Virginia Senate Backs Vape Tax Increase to Offset Income Tax Cut
West Virginia Senate Backs Vape Tax Increase to Offset Income Tax Cut
The West Virginia Senate approved a 10% personal income tax cut on February 22, 2026, with part of the revenue offset coming from increased excise taxes on vape and e-cigarette products.
News
Feb.23
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
Michigan Senate Bill 786 Seeks to Ban Sale of Vapes With Metal Heating Elements
Michigan Senate Bill 786 Seeks to Ban Sale of Vapes With Metal Heating Elements
Michigan lawmakers introduced Senate Bill 786 on February 18, 2026, proposing to prohibit the sale or transfer of vapor products that contain heating elements unless those elements are made of or encased in glass or ceramic materials
Regulations
Feb.21
Oregon Senate Passes Bill to Regulate Nicotine Pouches as Tobacco Products
Oregon Senate Passes Bill to Regulate Nicotine Pouches as Tobacco Products
The Oregon Senate voted 26–1 to pass Senate Bill 1571, a measure redefining tobacco products to include nicotine pouches and restricting their sale to individuals under 21.
Regulations
Feb.23
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11